Metropolitan Life Insurance Company (MetLife)’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-24,149	Closed	-$729K	–	2703
2016 Q2	$729K	Buy	+24,149	New	+$490K	0.01%	1456

Metropolitan Life Insurance Company (MetLife)'s CPXX Position: Q3 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 24,149 shares — an estimated $729K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $729K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Metropolitan Life Insurance Company (MetLife) reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 24,149 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $729K.
Metropolitan Life Insurance Company (MetLife) first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Metropolitan Life Insurance Company (MetLife)'s CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $729K in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2016, filed 15 Nov 2016.